Comparison of competing‐risks model with angiogenic factors in midgestation screening for preterm growth‐related neonatal morbidity
Ultrasound in Obstetrics & Gynecology · 2024
DOI: 10.1002/uog.27559 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Ultrasound in Obstetrics & Gynecology, 2024. Verfasst von I Papastefanou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Women and Children's Health, School of Life Course and Population Sciences, Faculty of Life Sciences & Medicine, King's College London,…. Hauptthemen laut MEDLINE: Placenta Growth Factor, Vascular Endothelial Growth Factor Receptor-1, Infant, Small for Gestational Age, Ultrasonography, Prenatal. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Fetal Medicine Foundation.
Abstract (Originalsprache)
Objectives
First, to evaluate the predictive performance for preterm growth‐related neonatal morbidity of a high soluble fms‐like tyrosine kinase‐1 (sFlt‐1)/placental growth factor (PlGF) ratio or low PlGF at midgestation and, second, to compare the performance of a high sFlt‐1/PlGF ratio or low PlGF with that of the competing‐risks model for small‐for‐gestational age (SGA), utilizing a combination of maternal risk factors, sonographic estimated fetal weight and uterine artery pulsatility index.
Methods
This was a prospective observational study in women attending for a routine hospital visit at 19–24 weeks' gestation in two maternity hospitals in England. The visit included recording of maternal demographic characteristics and medical history, carrying out an ultrasound scan and measuring serum PlGF and sFlt‐1. The primary outcome was delivery < 32 and < 37 weeks' gestation of a SGA neonate with birth weight < 10 th or < 3 rd percentile, combined with neonatal unit (NNU) admission for ≥ 48 h or a composite of major neonatal morbidity. The detection rates in screening by PlGF < 10 th percentile, sFlt‐1/PlGF ratio > 90 th percentile and the competing‐risks model for SGA were estimated and then compared using McNemar's test.
Results
In the study population of 40 241 women, prediction of preterm growth‐related neonatal morbidity provided by the competing‐risks model for SGA was superior to that of screening by low PlGF concentration or high sFlt‐1/PlGF ratio. For example, at a screen‐positive rate of 10.0%, as defined by the sFlt‐1/PlGF ratio > 90 th percentile, the competing‐risks model predicted 70.1% (95% CI, 61.0–79.2%) of SGA < 10 th percentile and 76.9% (95% CI, 67.6–86.3%) of SGA < 3 rd percentile with NNU admission for ≥ 48 h delivered < 32 weeks' gestation. The respective values for SGA with major neonatal morbidity were 73.8% (95% CI, 64.4–83.2%) and 77.9% (95% CI, 68.0–87.8%). These were significantly higher than the respective values of 35.1% (95% CI, 25.6–44.6%), 35.9% (95% CI, 25.3–46.5%), 38.1% (95% CI, 27.7–48.5%) and 39.7% (95% CI, 28.1–51.3%) achieved by the application of the sFlt‐1/PlGF ratio > 90 th percentile (all P < 0.0001).
Conclusion
At midgestation, the prediction of growth‐related neonatal morbidity by the competing‐risks model for SGA is superior to that of a high sFlt‐1/PlGF ratio or low PlGF. © 2023 International Society of Ultrasound in Obstetrics and Gynecology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Women and Children's Health, School of Life Course and Population Sciences, Faculty of Life Sciences & Medicine, King's College London, London, UK.
- Fetal Medicine Research Institute, King's College Hospital, London, UK.
ORCID-Profile: I Papastefanou, A Syngelaki
Förderung
- Fetal Medicine Foundation
Zitieren
APA
Papastefanou, I., Menenez, M., Szczepkowska, A., Gungil, B., Syngelaki, A., & Nicolaides, K. H. (2024). Comparison of competing‐risks model with angiogenic factors in midgestation screening for preterm growth‐related neonatal morbidity. Ultrasound in Obstetrics & Gynecology. https://doi.org/10.1002/uog.27559
Vancouver
Papastefanou I, Menenez M, Szczepkowska A, Gungil B, Syngelaki A, Nicolaides KH. Comparison of competing‐risks model with angiogenic factors in midgestation screening for preterm growth‐related neonatal morbidity. Ultrasound in Obstetrics & Gynecology. 2024. doi:10.1002/uog.27559
BibTeX
@article{Papastefanou2024,
author = {Papastefanou, I and Menenez, M and Szczepkowska, A and Gungil, B and Syngelaki, A and Nicolaides, K H},
title = {Comparison of competing‐risks model with angiogenic factors in midgestation screening for preterm growth‐related neonatal morbidity},
journal = {Ultrasound in Obstetrics & Gynecology},
year = {2024},
doi = {10.1002/uog.27559}
}
EUVIMED